Home > Boards > US Listed > Medical - Drugs > GlaxoSmithKline (GSK)

SITCDecitabine gene modulation sensitizes human non–small cell lung

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
jondoeuk Member Profile
 
Followed By 18
Posts 1,664
Boards Moderated 1
Alias Born 10/24/15
160x600 placeholder
CureVac right-sizes COVID-19 vaccine manufacturing in response to changes in demand Seeking Alpha - 9/14/2021 8:10:27 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/13/2021 1:49:57 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/9/2021 12:36:10 PM
Dosing underway in Alector's Phase 2 AL001 study in amyotrophic lateral sclerosis Seeking Alpha - 9/9/2021 9:44:57 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/7/2021 1:38:17 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/3/2021 7:19:10 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/1/2021 9:12:53 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/31/2021 8:04:42 AM
GlaxoSmithKline, SK Bioscience Begin Phase 3 Trial of Covid-19 Vaccine Dow Jones News - 8/31/2021 2:50:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/25/2021 9:44:47 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/23/2021 12:55:49 PM
Merck KGaA halts mid-stage trial for bintrafusp alfa in biliary tract cancer Seeking Alpha - 8/23/2021 12:03:22 PM
AnaptysBio Up 10% on GSK Drug Indication Approval Dow Jones News - 8/17/2021 6:50:00 PM
Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a) Edgar (US Regulatory) - 8/13/2021 7:07:24 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/11/2021 10:02:12 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/11/2021 8:50:54 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/5/2021 7:30:18 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/2/2021 9:47:56 AM
GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps Business Wire - 7/29/2021 6:03:00 PM
GlaxoSmithKline announces FDA approval of Nucala for new eosinophilic-driven indication Seeking Alpha - 7/29/2021 3:04:24 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/28/2021 1:36:39 PM
GlaxoSmithKline 2Q Net Profit Fell Despite Higher Sales; Backs 2021 Outlook -- Update Dow Jones News - 7/28/2021 8:52:00 AM
GlaxoSmithKline posts Q2 earnings beat, maintains FY forecast Seeking Alpha - 7/28/2021 8:20:29 AM
GlaxoSmithKline 2Q Net Profit Drops Despite Higher Sales; Backs 2021 Outlook Dow Jones News - 7/28/2021 7:39:00 AM
GlaxoSmithKline, Vir Biotechnology to Supply Covid-19 Treatment to European Commission Dow Jones News - 7/28/2021 7:18:00 AM
jondoeuk   Wednesday, 10/14/20 07:18:45 PM
Re: None
Post # of 167 
SITC

Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo

Modeling the efficacy of NY-ESO-1 TCR T cells (letetresgene autoleucel; GSK3377794) in patients with synovial sarcoma: correlations of response with transduced cell kinetics and biomarkers

Final analysis of the Phase 1 trial of NY-ESO-1–specific T-cell receptor (TCR) T-cell therapy (letetresgene autoleucel; GSK3377794) in patients with advanced synovial sarcoma (SS)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences